A recent $1 billion deal between PTC Therapeutics and Novartis for a Huntington’sdisease treatment highlights a growing interest in this sector, suggesting a similar valuation could be achievable ...
Tapering. Spaghetti plots show that CSF NFL (right) rises more quickly in people with ADAD mutations (red) than in noncarriers (gray) and that this accelerates as disease progresses. In plasma (left), ...